CHM_MSKCC
@CHM_MSKCC
Followers
811
Following
130
Media
24
Statuses
191
Center for Hematologic Malignancies @MSKCC. Accelerating biology & treatment of #BloodCancers.
New York, NY
Joined September 2017
RT @TaylorJ_MD: That’s an amazing illustration! You’ve got great talent. And of course congrats to @AbdelWahablab & @bradleybio!.
0
1
0
RT @AbdelWahablab: Excited to share our collaboration w/ @bradleybio demonstrating that pharmacologic modulation of splicing induces immun….
cell.com
By provoking production of “neoantigens” that are recognized by immune cells, drugs that modulate RNA splicing can enhance cancer immunotherapy.
0
54
0
RT @KharasLab: TOMORROW IS THE DEADLINE FOR FASEB 2021 ABSTRACTS JUNE 25TH 2021 FASEB HEME MALIGNANCIES!!! SPEAKER SLOTS, TEASER TALKS, AND….
0
6
0
Check out this Excellent work from @KharasLab and others out @Cancer_Cell! Congrats to all!.
So excited and congrats to Yuanming Cheng @kharasLab, Wei Xie (Patel Lab), and all of our collaborators on their paper uncovering the role for the m6A reader YTHDC1 in AML and its ability to form dynamic nuclear condensates! .@Cancer_Cell @CHM_MSKCC.
0
0
3
RT @KentsisResearch: Research Shows How Common Feature of Blood Cancers Can Be Targeted
mskcc.org
Research points to the role of a protein called MYB, which has long been known to play a role in cancer.
0
12
0
RT @CLLAdvocates: Please RT & join us on 11th Feb 4-5:30pm CET our extensive panel of experts discuss COVID-19 vaccination and immune chall….
0
14
0
RT @RichardKoche: Very happy to see our paper on enhancer hijacking determining MYCN amplicon architecture in neuroblastoma chosen for an E….
nature.com
On this page we provide a snapshot of some of the most exciting works recently published in Nature Communications in cancer research. We cover all aspects of ...
0
7
0
RT @MSKCC_Library: The Tow Center for #DevelopmentalOncology officially launches today! Congrats to Director @oleg8r and all others involve….
mskcc.org
The Tow Center for Developmental Oncology (TCDO) at MSK Kids and Memorial Sloan Kettering Cancer Center focuses on developing ground-breaking treatments for cancers in children and young adults.
0
5
0
RT @KentsisResearch: A new year for new science and a new science publishing model: Convergent organization of aberrant MYB complex control….
0
4
0
Sloan Kettering Institute Scientists Solve a 100-Year-Old Mystery about Cancer | Memorial Sloan Kettering Cancer Center
mskcc.org
Scientists have long known that cancer cells and immune cells have an uncommon hunger for glucose but haven’t understood why. A new study offers an answer.
0
4
9
RT @LoweLabMSKCC: Congratulations to postdoc @ScottMillmanMD on being selected by @ASH_hematology to receive an ASH Scholar Award! Scott wi….
0
1
0
RT @MskccCMO: Amidst the many firsts of 2021, we present our first @MskccCMO #Twinterview of the year, featuring Sarah Phillips Suehnholz @….
0
6
0
RT @FlowMskcc: Folkss, the latest #OpenFlow session (with amazing @CrickTraining) is on YouTube!. "Full Spectrum #FlowCytometry Part II - P….
0
3
0
RT @TheDoctorIsVin: Very grateful for the support of @columbiacancer @CSCIColumbia @ColumbiaGenDev and @ASH_hematology. I stand on the shou….
0
1
0
Congrats @diunguyen_vn_uk @KharasLab on receiving the ASH Scholar Award! Her work will uncover differential translational programs in AML ➡️investigating mechanisms underlying the differential regulation of MSI2 in AML propagating LSCs & shed light on potential therapies. 🙌👏
2
1
8
RT @BCD_AACR: Just published #OnlineFirst: .A Therapeutic Strategy for Preferential Targeting of TET2 Mutant and TET-dioxygenase Deficient….
0
5
0
RT @PapaemmanuilLab: I could not be prouder for this paper "Isabl, a digital biobank for processing multimodal pat….
0
17
0